These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 1973585

  • 1. Dose-response relationship of the H1-histamine antagonist, ebastine, against histamine and methacholine-induced bronchoconstriction in patients with asthma.
    Wood-Baker R, Holgate ST.
    Agents Actions; 1990 Apr; 30(1-2):284-6. PubMed ID: 1973585
    [Abstract] [Full Text] [Related]

  • 2. Terfenadine (Seldane) is a potent and selective histamine H1 receptor antagonist in asthmatic airways.
    Rafferty P, Holgate ST.
    Am Rev Respir Dis; 1987 Jan; 135(1):181-4. PubMed ID: 2879489
    [Abstract] [Full Text] [Related]

  • 3. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.
    Antonijoan R, García-Gea C, Puntes M, Pérez J, Esbrí R, Serra C, Fortea J, Barbanoj MJ.
    Clin Ther; 2007 May; 29(5):814-822. PubMed ID: 17697901
    [Abstract] [Full Text] [Related]

  • 4. Effect of terfenadine on methacholine-induced bronchoconstriction in asthma.
    Patel KR.
    J Allergy Clin Immunol; 1987 Feb; 79(2):355-8. PubMed ID: 2880885
    [Abstract] [Full Text] [Related]

  • 5. Oxatomide modifies methacholine- and exercise-induced bronchoconstriction in asthmatic children.
    Kishida M, Sasamoto A, Saito S, Iikura Y.
    Ann Allergy; 1992 Nov; 69(5):455-61. PubMed ID: 1360776
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders.
    Wiseman LR, Faulds D.
    Drugs; 1996 Feb; 51(2):260-77. PubMed ID: 8808167
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The in vivo potency and selectivity of azelastine as an H1 histamine-receptor antagonist in human airways and skin.
    Rafferty P, Harrison PJ, Aurich R, Holgate ST.
    J Allergy Clin Immunol; 1988 Dec; 82(6):1113-8. PubMed ID: 2904931
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of ebastine, cetirizine, and loratadine in histamine cutaneous challenges.
    Gispert J, Antonijoan R, Barbanoj M, Gich I, Garcia E, Esbrí R, Luria X.
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):259-64. PubMed ID: 12269645
    [Abstract] [Full Text] [Related]

  • 11. Effects of a cyclo-oxygenase inhibitor, flurbiprofen, and an H1 histamine receptor antagonist, terfenadine, alone and in combination on allergen induced immediate bronchoconstriction in man.
    Curzen N, Rafferty P, Holgate ST.
    Thorax; 1987 Dec; 42(12):946-52. PubMed ID: 2894081
    [Abstract] [Full Text] [Related]

  • 12. Comparative antiallergic effects of second-generation H1-antihistamines ebastine, cetirizine and loratadine in preclinical models.
    Llupià J, Gras J, Llenas J.
    Arzneimittelforschung; 2003 Dec; 53(2):93-7. PubMed ID: 12642964
    [Abstract] [Full Text] [Related]

  • 13. Relation of the hypertonic saline responsiveness of the airways to exercise induced asthma symptom severity and to histamine or methacholine reactivity.
    Makker HK, Holgate ST.
    Thorax; 1993 Feb; 48(2):142-7. PubMed ID: 8493628
    [Abstract] [Full Text] [Related]

  • 14. Duration of the antihistaminic effect after discontinuation of ebastine.
    Frossard N, Vital-Durand D, Mounedji N, Valleteau A.
    Allergy; 2001 Jun; 56(6):553-7. PubMed ID: 11421903
    [Abstract] [Full Text] [Related]

  • 15. Effect of angiotensin II on histamine-induced bronchoconstriction in the human airway both in vitro and in vivo.
    Ramsay SG, Clayton RA, Dagg KD, Thomson LJ, Nally JE, Thomson NC.
    Respir Med; 1997 Nov; 91(10):609-15. PubMed ID: 9488894
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inhaled lysine acetylsalicylate (L-ASA) attenuates histamine-induced bronchoconstriction in asthma.
    Crimi N, Polosa R, Magrì S, Prosperini G, Paolino G, Mastruzzo C, Mistretta A.
    Allergy; 1996 Mar; 51(3):157-63. PubMed ID: 8781669
    [Abstract] [Full Text] [Related]

  • 18. Acute and subchronic effects of the H1-histamine receptor antagonist ebastine in 10, 20 and 30 mg dose, and triprolidine 10 mg on car driving performance.
    Brookhuis KA, De Vries G, De Waard D.
    Br J Clin Pharmacol; 1993 Jul; 36(1):67-70. PubMed ID: 8104017
    [Abstract] [Full Text] [Related]

  • 19. Effect of cetirizine, a new histamine H1 antagonist, on airway dynamics and responsiveness to inhaled histamine in mild asthma.
    Brik A, Tashkin DP, Gong H, Dauphinee B, Lee E.
    J Allergy Clin Immunol; 1987 Jul; 80(1):51-6. PubMed ID: 2885355
    [Abstract] [Full Text] [Related]

  • 20. The effect of inhaled ipratropium bromide alone and in combination with oral terfenadine on bronchoconstriction provoked by adenosine 5'-monophosphate and histamine in asthma.
    Polosa R, Phillips GD, Rajakulasingam K, Holgate ST.
    J Allergy Clin Immunol; 1991 May; 87(5):939-47. PubMed ID: 1673977
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.